Skip to main content
Top
Published in: Digestive Diseases and Sciences 8/2007

01-08-2007 | Original Paper

Proteomic Analysis of Protein Plugs: Causative Agent of Symptoms in Patients with Choledochal Cyst

Authors: Kenitiro Kaneko, Hisami Ando, Takahiko Seo, Yasuyuki Ono, Takahisa Tainaka, Wataru Sumida

Published in: Digestive Diseases and Sciences | Issue 8/2007

Login to get access

Abstract

Symptoms of choledochal cysts are caused by protein plugs. We performed proteomic analysis of protein plugs to elucidate formation mechanism. Protein plugs were obtained from three pediatric patients with choledochal cyst. Proteins were separated using sodium dodecyl sulfate–polyacrylamide gel electrophoresis. Gel bands common to the samples were excised for mass spectrometry. Mass spectra were compared with the NCBI database for protein identification. Gel bands of protein plug samples were predominant at 14 kilodaltons (kDa), followed by 29 kDa. Four other thin bands were common to the plug samples. Four bands (including 14 and 29 kDa) were identified as lithostathine, and one band as serum albumin. Plugs consisted mostly of lithostathine, a protein secreted by pancreatic acinar cells into pancreatic juice. The mechanism involves trypsinogen and lithostathine regurgitating into the cyst through an aberrant union of pancreaticobiliary ducts. Activated trypsin cleaves soluble lithostathine into insoluble forms that aggregate to form plugs.
Literature
1.
go back to reference Todani T, Watanabe Y, Naruse M, Tabuchi K, Okajima K (1977) Congenital bile duct cysts: classification, operative procedures, and review of thirty-seven cases including cancer arising from choledochal cyst. Am J Surg 134:263–269PubMedCrossRef Todani T, Watanabe Y, Naruse M, Tabuchi K, Okajima K (1977) Congenital bile duct cysts: classification, operative procedures, and review of thirty-seven cases including cancer arising from choledochal cyst. Am J Surg 134:263–269PubMedCrossRef
2.
go back to reference Todani T (1997) Congenital choledochal dilatation: classification, clinical features, and long-term results. J Hepatobil Pancreat Surg 4:276–282CrossRef Todani T (1997) Congenital choledochal dilatation: classification, clinical features, and long-term results. J Hepatobil Pancreat Surg 4:276–282CrossRef
3.
go back to reference Visser BC, Suh I, Way LW, Kang SM (2004) Congenital choledochal cysts in adults. Arch Surg 139:855–862PubMedCrossRef Visser BC, Suh I, Way LW, Kang SM (2004) Congenital choledochal cysts in adults. Arch Surg 139:855–862PubMedCrossRef
4.
go back to reference Japanese Study Group on Pancreaticobiliary Maljunction (JSPBM), Committee of JSPBM for Diagnostic Criteria (1994) Diagnostic criteria of pancreaticobiliary maljunction. J Hepatobil Pancreat Surg 1:219–221CrossRef Japanese Study Group on Pancreaticobiliary Maljunction (JSPBM), Committee of JSPBM for Diagnostic Criteria (1994) Diagnostic criteria of pancreaticobiliary maljunction. J Hepatobil Pancreat Surg 1:219–221CrossRef
5.
go back to reference Kaneko K, Ando H, Ito T, Watanabe Y, Seo T, Harada T, Ito F (1997) Protein plugs cause symptoms in patients with choledochal cysts. Am J Gastroenterol 92:1018–1021PubMed Kaneko K, Ando H, Ito T, Watanabe Y, Seo T, Harada T, Ito F (1997) Protein plugs cause symptoms in patients with choledochal cysts. Am J Gastroenterol 92:1018–1021PubMed
6.
go back to reference Kaneko K, Ando H, Ito T, Kasai K, Watanabe Y, Seo T (1996) Increased cell proliferation and transforming growth factor-alpha (TGF alpha) in the gall-bladder epithelium of patients with pancreaticobiliary maljunction. Pathol Int 46:253–260PubMedCrossRef Kaneko K, Ando H, Ito T, Kasai K, Watanabe Y, Seo T (1996) Increased cell proliferation and transforming growth factor-alpha (TGF alpha) in the gall-bladder epithelium of patients with pancreaticobiliary maljunction. Pathol Int 46:253–260PubMedCrossRef
7.
go back to reference Kaneko K, Ando H, Seo T, Ono Y, Ochiai K, Ogura Y (2005) Bile infection contributes to intrahepatic calculi formation after excision of choledochal cysts. Pediatr Surg Int 21:8–11PubMedCrossRef Kaneko K, Ando H, Seo T, Ono Y, Ochiai K, Ogura Y (2005) Bile infection contributes to intrahepatic calculi formation after excision of choledochal cysts. Pediatr Surg Int 21:8–11PubMedCrossRef
8.
go back to reference Maki T (1966) Pathogenesis of calcium bilirubinate stone: role of E. coli, b-glucuronidase and coagulation by inorganic ions, polyelectrolytes and agitation. Ann Surg 164:90–100PubMedCrossRef Maki T (1966) Pathogenesis of calcium bilirubinate stone: role of E. coli, b-glucuronidase and coagulation by inorganic ions, polyelectrolytes and agitation. Ann Surg 164:90–100PubMedCrossRef
9.
go back to reference Ando H, Ito T, Kaneko K, Seo T, Ito F (1996) Intrahepatic bile duct stenosis causing intrahepatic calculi formation following excision of a choledochal cyst. J Am Coll Surg 183:56–60PubMed Ando H, Ito T, Kaneko K, Seo T, Ito F (1996) Intrahepatic bile duct stenosis causing intrahepatic calculi formation following excision of a choledochal cyst. J Am Coll Surg 183:56–60PubMed
10.
go back to reference Uno K, Tsuchida Y, Kawarasaki H, Ohmiya H, Honna T (1996) Development of intrahepatic cholelithiasis long after primary excision of choledochal cysts. J Am Coll Surg 183:583–588PubMed Uno K, Tsuchida Y, Kawarasaki H, Ohmiya H, Honna T (1996) Development of intrahepatic cholelithiasis long after primary excision of choledochal cysts. J Am Coll Surg 183:583–588PubMed
11.
go back to reference Watanabe Y, Toki A, Todani T (1999) Bile duct cancer developed after cyst excision for choledochal cyst. J Hepatobil Pancreat Surg 6:207–212CrossRef Watanabe Y, Toki A, Todani T (1999) Bile duct cancer developed after cyst excision for choledochal cyst. J Hepatobil Pancreat Surg 6:207–212CrossRef
12.
go back to reference Kobayashi S, Asano T, Yamasaki M, Kenmochi T, Nakagohri T, Ochiai T (1999) Risk of bile duct carcinogenesis after excision of extrahepatic bile ducts in pancreaticobiliary maljunction. Surgery 126:939–944PubMedCrossRef Kobayashi S, Asano T, Yamasaki M, Kenmochi T, Nakagohri T, Ochiai T (1999) Risk of bile duct carcinogenesis after excision of extrahepatic bile ducts in pancreaticobiliary maljunction. Surgery 126:939–944PubMedCrossRef
13.
go back to reference Goto N, Yasuda I, Uematsu T, Kanemura N, Takai S, Ando K, Kato T, Osada S, Takao H, Saji S, Shimokawa K, Moriwaki H (2001) Intrahepatic cholangiocarcinoma arising 10 years after the excision of congenital extrahepatic biliary dilation. J Gastroenterol 36:856–862PubMedCrossRef Goto N, Yasuda I, Uematsu T, Kanemura N, Takai S, Ando K, Kato T, Osada S, Takao H, Saji S, Shimokawa K, Moriwaki H (2001) Intrahepatic cholangiocarcinoma arising 10 years after the excision of congenital extrahepatic biliary dilation. J Gastroenterol 36:856–862PubMedCrossRef
14.
go back to reference Tsuchida A, Kasuya K, Endo M, Saito H, Inoue K, Nagae I, Aoki T, Koyanagi Y (2003) High risk of bile duct carcinogenesis after primary resection of a congenital biliary dilatation. Oncol Rep 10:1183–1187PubMed Tsuchida A, Kasuya K, Endo M, Saito H, Inoue K, Nagae I, Aoki T, Koyanagi Y (2003) High risk of bile duct carcinogenesis after primary resection of a congenital biliary dilatation. Oncol Rep 10:1183–1187PubMed
15.
go back to reference Ando H, Ito T, Watanabe Y, Seo T, Kaneko K, Nagaya M (1995) Spontaneous perforation of choledochal cyst. J Am Coll Surg 181:125–128PubMed Ando H, Ito T, Watanabe Y, Seo T, Kaneko K, Nagaya M (1995) Spontaneous perforation of choledochal cyst. J Am Coll Surg 181:125–128PubMed
16.
go back to reference Ando H, Ito T, Nagaya M, Watanabe Y, Seo T, Kaneko K (1995) Pancreaticobiliary maljunction without choledochal cysts in infants and children: clinical features and surgical therapy. J Pediatr Surg 30:1658–1662PubMedCrossRef Ando H, Ito T, Nagaya M, Watanabe Y, Seo T, Kaneko K (1995) Pancreaticobiliary maljunction without choledochal cysts in infants and children: clinical features and surgical therapy. J Pediatr Surg 30:1658–1662PubMedCrossRef
17.
go back to reference Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68:850–858PubMedCrossRef Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68:850–858PubMedCrossRef
18.
go back to reference Giorgi D, Bernard JP, Rouquier S, Iovanna J, Sarles H, Dagorn JC (1989) Secretory pancreatic stone protein messenger RNA. Nucleotide sequence and expression in chronic calcifying pancreatitis. J Clin Invest 84:100–106PubMedCrossRef Giorgi D, Bernard JP, Rouquier S, Iovanna J, Sarles H, Dagorn JC (1989) Secretory pancreatic stone protein messenger RNA. Nucleotide sequence and expression in chronic calcifying pancreatitis. J Clin Invest 84:100–106PubMedCrossRef
19.
go back to reference Watanabe T, Yonekura H, Terazono K, Yamamoto H, Okamoto H (1990) Complete nucleotide sequence of human reg gene and its expression in normal and tumoral tissues: the reg protien, pancreatic stone protein, and pancreatic thread protein are one and the same product of the gene. J Biol Chem 265:7432–7439PubMed Watanabe T, Yonekura H, Terazono K, Yamamoto H, Okamoto H (1990) Complete nucleotide sequence of human reg gene and its expression in normal and tumoral tissues: the reg protien, pancreatic stone protein, and pancreatic thread protein are one and the same product of the gene. J Biol Chem 265:7432–7439PubMed
20.
go back to reference Patard L, Lallemand JY, Stoven V (2003) An insight into the role of human pancreatic lithostathine. JOP 4:92–103PubMed Patard L, Lallemand JY, Stoven V (2003) An insight into the role of human pancreatic lithostathine. JOP 4:92–103PubMed
21.
go back to reference Provansal-Cheylan M, Mariani A, Bernard JP, Sarles H, Dupuy P (1989) Pancreatic stone protein: quantification in pancreatic juice by enzyme-linked immunosorbent assay and comparison with other methods. Pancreas 4:680–689PubMedCrossRef Provansal-Cheylan M, Mariani A, Bernard JP, Sarles H, Dupuy P (1989) Pancreatic stone protein: quantification in pancreatic juice by enzyme-linked immunosorbent assay and comparison with other methods. Pancreas 4:680–689PubMedCrossRef
22.
go back to reference Schmiegel W, Burchert M, Kalthoff H, Roeder C, Butzow G, Grimm H, Kremer B, Soehendra N, Schreiber HW, Thiele HG, Greten H (1990) Immunochemical characterization and quantitative distribution of pancreatic stone protein in sera and pancreatic secretions in pancreatic disorders. Gastroenterology 99:1421–1430PubMed Schmiegel W, Burchert M, Kalthoff H, Roeder C, Butzow G, Grimm H, Kremer B, Soehendra N, Schreiber HW, Thiele HG, Greten H (1990) Immunochemical characterization and quantitative distribution of pancreatic stone protein in sera and pancreatic secretions in pancreatic disorders. Gastroenterology 99:1421–1430PubMed
23.
go back to reference Lee BI, Mustafi D, Cho W, Nakagawa Y (2003) Characterization of calcium binding properties of lithostathine. J Biol Inorg Chem 8:341–347PubMed Lee BI, Mustafi D, Cho W, Nakagawa Y (2003) Characterization of calcium binding properties of lithostathine. J Biol Inorg Chem 8:341–347PubMed
24.
go back to reference Gregoire C, Marco S, Thimonier J, Duplan L, Laurine E, Chauvin JP, Michel B, Peyrot V, Verdier JM (2001) Three-dimensional structure of the lithostathine protofibril, a protein involved in Alzheimer's disease. EMBO J 20:3313–3321PubMedCrossRef Gregoire C, Marco S, Thimonier J, Duplan L, Laurine E, Chauvin JP, Michel B, Peyrot V, Verdier JM (2001) Three-dimensional structure of the lithostathine protofibril, a protein involved in Alzheimer's disease. EMBO J 20:3313–3321PubMedCrossRef
25.
go back to reference Graf R, Schiesser M, Scheele GA, Marquardt K, Frick TW, Ammann RW, Bimmler D (2001) A family of 16-kDa pancreatic secretory stress proteins form highly organized fibrillar structures upon tryptic activation. J Biol Chem 276:21028–21038PubMedCrossRef Graf R, Schiesser M, Scheele GA, Marquardt K, Frick TW, Ammann RW, Bimmler D (2001) A family of 16-kDa pancreatic secretory stress proteins form highly organized fibrillar structures upon tryptic activation. J Biol Chem 276:21028–21038PubMedCrossRef
26.
go back to reference Iovanna JL, Dagorn JC (2005) The multifunctional family of secreted proteins containing a C-type lectin-like domain linked to a short N-terminal peptide. Biochim Biophys Acta 1723:8–18PubMed Iovanna JL, Dagorn JC (2005) The multifunctional family of secreted proteins containing a C-type lectin-like domain linked to a short N-terminal peptide. Biochim Biophys Acta 1723:8–18PubMed
27.
go back to reference Guy O, Robles-Diaz G, Adrich Z, Sahel J, Sarles H (1983) Protein content of precipitates present in pancreatic juice of alcoholic subjects and patients with chronic calcifying pancreatitis. Gastroenterology 84:102–107PubMed Guy O, Robles-Diaz G, Adrich Z, Sahel J, Sarles H (1983) Protein content of precipitates present in pancreatic juice of alcoholic subjects and patients with chronic calcifying pancreatitis. Gastroenterology 84:102–107PubMed
28.
go back to reference Multigner L, Daudon M, Montalto G, De Caro A, Etienne JP, Sarles H (1986) Radiolucent pancreatic stones. N Engl J Med 314:248PubMed Multigner L, Daudon M, Montalto G, De Caro A, Etienne JP, Sarles H (1986) Radiolucent pancreatic stones. N Engl J Med 314:248PubMed
29.
go back to reference Mariani A, Bernard JP, Provansal-Cheylan M, Nitsche S, Sarles H (1991) Differnces of pancreatic stone morphology and content in patients with pancreatic lithiasis. Dig Dis Sci 36:1509–1516CrossRefPubMed Mariani A, Bernard JP, Provansal-Cheylan M, Nitsche S, Sarles H (1991) Differnces of pancreatic stone morphology and content in patients with pancreatic lithiasis. Dig Dis Sci 36:1509–1516CrossRefPubMed
30.
go back to reference Ozturk M, de la Monte SM, Gross J, Wands JR (1989) Elevated leveld of an exocrine pancreatic secretory protein in Alzheimer disease brain. Proc Natl Acad Sci USA 86:419–423PubMedCrossRef Ozturk M, de la Monte SM, Gross J, Wands JR (1989) Elevated leveld of an exocrine pancreatic secretory protein in Alzheimer disease brain. Proc Natl Acad Sci USA 86:419–423PubMedCrossRef
31.
go back to reference Laurine E, Gregoire C, Fandrich M, Engemann S, Marchal S, Thion L, Mohr M, Monsarrat B, Michel B, Dobson CM, Wanker E, Erard M, Verdier JM (2003) Lithostathine quadruple-helical filaments form proteinase K-resistant deposits in Creutzfeldt-Jakob disease. J Bio Chem 51:51770–51778CrossRef Laurine E, Gregoire C, Fandrich M, Engemann S, Marchal S, Thion L, Mohr M, Monsarrat B, Michel B, Dobson CM, Wanker E, Erard M, Verdier JM (2003) Lithostathine quadruple-helical filaments form proteinase K-resistant deposits in Creutzfeldt-Jakob disease. J Bio Chem 51:51770–51778CrossRef
32.
go back to reference Duplan L, Michel B, Boucraut J, Barthellemy S, Desplat-Jego S, Marin V, Gambarelli D, Bernard D, Berthezene P, Alescio-Lautier B, Verdier JM (2001) Lithostathine and pancreatitis-associated protein are involved in the very early stages of Alzheimer's disease. Neurobiol Aging 22:79–88PubMedCrossRef Duplan L, Michel B, Boucraut J, Barthellemy S, Desplat-Jego S, Marin V, Gambarelli D, Bernard D, Berthezene P, Alescio-Lautier B, Verdier JM (2001) Lithostathine and pancreatitis-associated protein are involved in the very early stages of Alzheimer's disease. Neurobiol Aging 22:79–88PubMedCrossRef
33.
go back to reference Kaneko K, Ando H, Watanabe Y, Seo T, Harada T (2000) Pathologic changes in the common bile duct of an experimental model with pancreaticobiliary maljunction. Pediatr Surg Int 16:26–28PubMedCrossRef Kaneko K, Ando H, Watanabe Y, Seo T, Harada T (2000) Pathologic changes in the common bile duct of an experimental model with pancreaticobiliary maljunction. Pediatr Surg Int 16:26–28PubMedCrossRef
34.
go back to reference Kristiansen TZ, Bunkenborg J, Gronborg M, Molina H, Thuluvath PJ, Argani P, Goggins MG, Maitra A, Pandey A (2004) A proteomic analysis of human bile. Mol Cell Proteomics 3:715–728PubMedCrossRef Kristiansen TZ, Bunkenborg J, Gronborg M, Molina H, Thuluvath PJ, Argani P, Goggins MG, Maitra A, Pandey A (2004) A proteomic analysis of human bile. Mol Cell Proteomics 3:715–728PubMedCrossRef
35.
go back to reference Zhou H, Chen B, Li RX, Sheng QH, Li SJ, Zhang L, Li L, Xia QC, Wang HY, Zeng R (2005) Large-scale identification of human biliary proteins from a cholesterol stone patient using a proteomic approach. Rapid Commun Mass Spectrom 19;3569–3578PubMedCrossRef Zhou H, Chen B, Li RX, Sheng QH, Li SJ, Zhang L, Li L, Xia QC, Wang HY, Zeng R (2005) Large-scale identification of human biliary proteins from a cholesterol stone patient using a proteomic approach. Rapid Commun Mass Spectrom 19;3569–3578PubMedCrossRef
36.
go back to reference Grønborg M, Bunkenborg J, Kristiansen TZ, Jensen ON, Yeo CJ, Hruban RH, Maitra A, Goggins MG, Pandey A (2004) Comprehensive proteomic analysis of human pancreatic juice. J Proteome Res 3:1042–1055PubMedCrossRef Grønborg M, Bunkenborg J, Kristiansen TZ, Jensen ON, Yeo CJ, Hruban RH, Maitra A, Goggins MG, Pandey A (2004) Comprehensive proteomic analysis of human pancreatic juice. J Proteome Res 3:1042–1055PubMedCrossRef
37.
go back to reference He XM, Carter DC (1992) Atomic structure and chemistry of human serum albumin. Nature 358:209–215PubMedCrossRef He XM, Carter DC (1992) Atomic structure and chemistry of human serum albumin. Nature 358:209–215PubMedCrossRef
38.
go back to reference Smits ME, Groen AK, Mok KS, van Marle J, Tytgat GN, Huibregtse K (1997) Analysis of occluded pancreatic stents and juices in patients with chronic pancreatitis. Gastrointest Endosc 45:52–58PubMedCrossRef Smits ME, Groen AK, Mok KS, van Marle J, Tytgat GN, Huibregtse K (1997) Analysis of occluded pancreatic stents and juices in patients with chronic pancreatitis. Gastrointest Endosc 45:52–58PubMedCrossRef
39.
go back to reference Farnbacher MJ, Voll RE, Faissner R, Wehler M, Hahn EG, Lohr M, Schneider HT (2005) Composition of clogging material in pancreatic endoprostheses. Gastrointest Endosc 61:862–866PubMedCrossRef Farnbacher MJ, Voll RE, Faissner R, Wehler M, Hahn EG, Lohr M, Schneider HT (2005) Composition of clogging material in pancreatic endoprostheses. Gastrointest Endosc 61:862–866PubMedCrossRef
40.
go back to reference Ochiai K, Kaneko K, Kitagawa M, Ando H, Hayakawa T (2004) Activated pancreatic enzyme and pancreatic stone protein (PSP/reg) in bile of patients with pancreaticobiliary maljunction/choledochal cyst. Dig Dis Sci 49:1953–1956PubMedCrossRef Ochiai K, Kaneko K, Kitagawa M, Ando H, Hayakawa T (2004) Activated pancreatic enzyme and pancreatic stone protein (PSP/reg) in bile of patients with pancreaticobiliary maljunction/choledochal cyst. Dig Dis Sci 49:1953–1956PubMedCrossRef
41.
go back to reference Bensimon G, Lacomblez L, Meininger V (1994) A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 330:585–591PubMedCrossRef Bensimon G, Lacomblez L, Meininger V (1994) A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 330:585–591PubMedCrossRef
42.
go back to reference Heiser V, Engemann S, Brocker W, Dunkel I, Boeddrich A, Waelter S, Nordhoff E, Lurz R, Schugardt N, Rautenberg S, Herhaus C, Barnickel G, Bottcher H, Lehrach H, Wanker EE (2002) Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay. Proc Natl Acad Sci USA 99:16400–16406PubMedCrossRef Heiser V, Engemann S, Brocker W, Dunkel I, Boeddrich A, Waelter S, Nordhoff E, Lurz R, Schugardt N, Rautenberg S, Herhaus C, Barnickel G, Bottcher H, Lehrach H, Wanker EE (2002) Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay. Proc Natl Acad Sci USA 99:16400–16406PubMedCrossRef
43.
go back to reference Huntington Study Group (2003) Dosage effects of riluzole in Huntington's disease. A multicenter placebo-controlled study. Neurology 61:1551–1556 Huntington Study Group (2003) Dosage effects of riluzole in Huntington's disease. A multicenter placebo-controlled study. Neurology 61:1551–1556
44.
go back to reference Tsuchida A, Itoi T, Kasuya K, Endo M, Katsumata K, Aoki T, Suzuki M, Aoki T (2005) Inhibitory effect of meloxicam, a cyclooxygenase-2 inhibitor, on N-nitrosobis (2-oxopropyl) amine induced biliary carcinogenesis in Syrian hamsters. Carcinogenesis 26:1922–1928PubMedCrossRef Tsuchida A, Itoi T, Kasuya K, Endo M, Katsumata K, Aoki T, Suzuki M, Aoki T (2005) Inhibitory effect of meloxicam, a cyclooxygenase-2 inhibitor, on N-nitrosobis (2-oxopropyl) amine induced biliary carcinogenesis in Syrian hamsters. Carcinogenesis 26:1922–1928PubMedCrossRef
Metadata
Title
Proteomic Analysis of Protein Plugs: Causative Agent of Symptoms in Patients with Choledochal Cyst
Authors
Kenitiro Kaneko
Hisami Ando
Takahiko Seo
Yasuyuki Ono
Takahisa Tainaka
Wataru Sumida
Publication date
01-08-2007
Published in
Digestive Diseases and Sciences / Issue 8/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9398-4

Other articles of this Issue 8/2007

Digestive Diseases and Sciences 8/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.